Zacks Research Estimates Allegion’s Q2 Earnings (NYSE:ALLE)

Allegion PLC (NYSE:ALLEFree Report) – Stock analysts at Zacks Research increased their Q2 2026 earnings per share estimates for shares of Allegion in a report issued on Tuesday, May 19th. Zacks Research analyst Team now anticipates that the scientific and technical instruments company will post earnings per share of $2.23 for the quarter, up from their prior estimate of $2.22. The consensus estimate for Allegion’s current full-year earnings is $8.73 per share. Zacks Research also issued estimates for Allegion’s Q3 2026 earnings at $2.45 EPS, Q4 2026 earnings at $2.24 EPS, FY2026 earnings at $8.72 EPS, Q1 2027 earnings at $2.01 EPS, Q2 2027 earnings at $2.36 EPS, Q3 2027 earnings at $2.49 EPS, Q4 2027 earnings at $2.34 EPS, FY2027 earnings at $9.20 EPS, Q1 2028 earnings at $2.15 EPS and FY2028 earnings at $10.01 EPS.

ALLE has been the subject of several other reports. Wells Fargo & Company lowered their price objective on shares of Allegion from $175.00 to $155.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 1st. Weiss Ratings downgraded shares of Allegion from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, May 1st. Barclays lowered their price target on Allegion from $165.00 to $161.00 and set an “equal weight” rating for the company in a report on Wednesday, April 29th. Robert W. Baird set a $165.00 price objective on Allegion in a research note on Wednesday, April 29th. Finally, Bank of America reduced their price objective on Allegion from $185.00 to $157.00 and set a “neutral” rating on the stock in a report on Monday, April 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $161.50.

View Our Latest Analysis on ALLE

Allegion Trading Up 2.3%

NYSE ALLE opened at $129.07 on Thursday. The stock has a market cap of $11.09 billion, a PE ratio of 17.63, a PEG ratio of 2.62 and a beta of 0.89. Allegion has a 12 month low of $125.00 and a 12 month high of $183.11. The company’s 50-day moving average price is $141.00 and its 200-day moving average price is $155.75. The company has a current ratio of 1.91, a quick ratio of 1.19 and a debt-to-equity ratio of 0.97.

Allegion (NYSE:ALLEGet Free Report) last released its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.80 earnings per share for the quarter, missing analysts’ consensus estimates of $1.88 by ($0.08). Allegion had a return on equity of 35.41% and a net margin of 15.24%.The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the previous year, the business earned $1.86 EPS. The business’s revenue for the quarter was up 9.7% on a year-over-year basis. Allegion has set its FY 2026 guidance at 8.700-8.900 EPS.

Allegion Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be paid a dividend of $0.55 per share. The ex-dividend date is Monday, June 15th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 1.7%. Allegion’s dividend payout ratio (DPR) is currently 30.05%.

Allegion declared that its Board of Directors has initiated a share repurchase program on Tuesday, April 28th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the scientific and technical instruments company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Insider Activity at Allegion

In other Allegion news, Director Sue Main acquired 2,000 shares of Allegion stock in a transaction that occurred on Wednesday, March 11th. The stock was bought at an average price of $149.61 per share, with a total value of $299,220.00. Following the completion of the purchase, the director directly owned 2,000 shares of the company’s stock, valued at approximately $299,220. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Robert C. Martens sold 3,993 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $137.15, for a total value of $547,639.95. Following the sale, the senior vice president owned 8,570 shares of the company’s stock, valued at approximately $1,175,375.50. This represents a 31.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Allegion

Institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Allegion by 7.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,592 shares of the scientific and technical instruments company’s stock valued at $1,251,000 after buying an additional 626 shares in the last quarter. NewEdge Advisors LLC raised its stake in shares of Allegion by 35.3% during the 1st quarter. NewEdge Advisors LLC now owns 3,272 shares of the scientific and technical instruments company’s stock worth $427,000 after acquiring an additional 854 shares in the last quarter. Jones Financial Companies Lllp lifted its position in Allegion by 44.2% during the first quarter. Jones Financial Companies Lllp now owns 1,629 shares of the scientific and technical instruments company’s stock valued at $213,000 after acquiring an additional 499 shares during the last quarter. Empowered Funds LLC boosted its stake in Allegion by 13.0% in the first quarter. Empowered Funds LLC now owns 5,673 shares of the scientific and technical instruments company’s stock valued at $740,000 after acquiring an additional 651 shares in the last quarter. Finally, Focus Partners Wealth grew its holdings in Allegion by 204.5% in the first quarter. Focus Partners Wealth now owns 7,186 shares of the scientific and technical instruments company’s stock worth $937,000 after purchasing an additional 4,826 shares during the last quarter. Institutional investors own 92.21% of the company’s stock.

Allegion Company Profile

(Get Free Report)

Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is head­quartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.

The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.

Featured Articles

Earnings History and Estimates for Allegion (NYSE:ALLE)

Receive News & Ratings for Allegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegion and related companies with MarketBeat.com's FREE daily email newsletter.